ArticleJournal of pain research2025
Determining the Effective Dose of Oliceridine Compounded with Propofol for Painless Hysteroscopy: A Prospective Modified Dixon Sequential Dose-Finding Study.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oliceridine combined with propofol is suitable for intravenous anesthesia in painless hysteroscopy. This study aimed to determine the 50% effective dose (ED Methods: In all, 29 patients aged 18-60 years who were scheduled for painless hysteroscopy under intravenous anesthesia were recruited, and a total of 26 patients were enrolled in the final analysis. The trial was conducted using the modified Dixon sequential method, with an initial dose of 1.5 mg of oliceridine, followed by 2.0-2.5 mg/kg of propofol administered 1 minute later. Whether the dose of oliceridine was increased or decreased depends on the prior operation. If the hysteroscopy failed (positive response), which was defined as inadequate cervical dilatation, patient body movements, frowning, heart rate (HR), or mean arterial pressure (MAP) greater than 20% of the baseline value, or a MOAA/S score ≥ 2, the subsequent dosage of oliceridine was increased by 0.1 mg. Conversely, the dose was decreased by 0.1 mg. At least seven crossover waves had to occur before the formal test was stopped. The probit regression method was used to determine the ED Results: The ED Conclusion: A dose of 1.848 mg oliceridine compounded with propofol provides an effective anesthesia approach for painless hysteroscopy. Future larger, multicenter studies will help to expand the population range of oliceridine use and explore its potential benefits and risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.